Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. (CON) Market Cap

Concentra Group Holdings Parent, Inc. has a market capitalization of $3.24B.

Price: $25.32

0.40 (1.61%)

Market Cap: 3.24B

NYSE · time unavailable

CEO: William Keith Newton

Sector: Healthcare

Industry: Medical - Equipment & Services

IPO Date: 2010-05-25

Website: https://www.concentra.com

Concentra Group Holdings Parent, Inc. (CON) - Company Information

Market Cap: 3.24B|Sector: Healthcare

Company Profile

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.

Analyst Sentiment

88%
Strong Buy

From 7 Active Polls

1Y Forecast: $31.00

▲ +22.4% Potential Upside

Consensus Target Metrics

Low Bound

$30

Median

$31

High Bound

$32

Average

$31

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$31.00
▲ +22.43% Upside
Low Target
$30.00
18% Risk
Median Target
$31.00
22% Mid
High Target
$32.00
26% Max
Consensus
Buy
5 / 5 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)3,2402,7172,4922,6512,6052,7482,5342,8472,846
Enterprise Value ($M)5,3014,7784,5154,7424,7114,8334,3024,6583,656
Price to Earnings Ratio (P/E)18.0213.4517.9613.7314.6217.6629.4516.0613.75
Price/Earnings-to-Growth Ratio (PEG)2.383.441.462.306.556.23
Price to Sales Ratio (P/S)1.454.774.624.634.735.495.455.825.95
Price to Book Ratio (P/B)7.556.406.346.887.608.959.1910.252.28
Price to Free Cash Flow Ratio (P/FCF)11.04273.5513.7867.2541.25-681.4432.9056.0951.58
Enterprise Value to Sales (EV/Sales)8.398.388.288.559.659.259.517.65
Enterprise Value to EBITDA (EV/EBITDA)12.3541.0150.1941.4543.4050.3157.6045.9237.18
Debt to Equity Ratio4.805.005.355.556.366.967.087.010.69

CON Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$25.32
Intrinsic Value$33.75
Market Alignment
Undervalued by 33.3%relative to calculated intrinsic value
9.00%
Exp: 6%6%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.45B
Perpetuity TV Value$8.43B
Discounted TV (PV)$3.56B
TV Weighting %60.8%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CONCENTRA GROUP HOLDINGS PARENT IN (CON) — Investment Overview

🧩 Business Model Overview

CON operates a network of occupational and healthcare clinics serving employers and their employees. The model is built around providing a care pathway for work-related and non-work urgent needs—typically including injury evaluation, diagnostic work-ups, treatment plans, rehabilitation/therapy services, and case management that connects clinical care with administrative workflows (documentation, claims support, and return-to-work outcomes).

Value is created by embedding into the employer’s operational process: clinicians and care coordinators interface with HR, safety, and benefits stakeholders to standardize intake, triage, and follow-up. This operational integration increases patient and employer stickiness because care is not a standalone transaction; it is part of a repeatable system employers use to manage risk, productivity, and compliance.

💰 Revenue Streams & Monetisation Model

Revenue is primarily derived from clinical visits and associated services delivered through the clinic network. Monetisation is supported by a mix of:

  • Employer- and insurer-linked occupational services (e.g., evaluations, treatment, and documentation tied to work-related claims).
  • Urgent care and episodic visits for conditions outside the occupational care pathway.
  • Rehabilitation/therapy and ancillary services connected to injury resolution and return-to-work plans.
  • Billing under established reimbursement frameworks, including negotiated rates and contract structures tied to payers, employers, and networks.

Margin drivers are influenced by clinic capacity utilization, staffing productivity, payer mix, reimbursement economics, and the degree to which treatment plans and follow-up reduce avoidable utilization. The business typically benefits when care pathways are managed efficiently (appropriate setting-of-care, standardized protocols, and effective rehabilitation execution) and when employer relationships produce predictable service volumes.

🧠 Competitive Advantages & Market Positioning

CON’s moat is driven primarily by switching costs and an operational/clinical integration advantage rather than pure geographic presence. Employers and payers value consistent processes: timely intake, standardized documentation, coordinated follow-up, and measurable return-to-work progress. Once embedded, replacing a care provider requires re-onboarding workflows, renegotiating contracting, and rebuilding trust in quality and administrative performance.

Switching costs arise from:

  • Administrative and documentation integration (forms, reporting, and care coordination workflows used for claims and compliance).
  • Continuity of care that improves outcomes when injuries are managed through consistent protocols and follow-up.
  • Contracted network relationships that make volume generation more reliable for an established provider.

Competitive benchmarking (primary peers):

  • American Family Care (AFC) — competes in urgent care and employer-facing services, typically with a more locally variable operational depth.
  • NextCare — competes in urgent care networks; employer relationships may exist, but occupational care coordination breadth can vary by market and provider depth.
  • Hospital outpatient and affiliated occupational medicine practices — compete on clinical capability and referral influence, but can face higher cost structures and less standardized employer-facing workflows.

Positioning contrast: Compared with urgent-care-first networks (AFC, NextCare) and hospital outpatient models, CON’s focus on occupational care pathways and employer-integrated administration increases stickiness. The market is fragmented at the clinic level, but employer decision-making tends to reward providers that standardize processes across sites and demonstrate operational reliability.

🚀 Multi-Year Growth Drivers

  • Secular employer demand for risk-managed care: Ongoing pressure to reduce workers’ compensation friction (timely triage, documentation accuracy, return-to-work velocity) supports sustained utilization of occupational care models.
  • Network density and throughput optimization: Adding clinic capacity and improving scheduling and care coordination can expand service volumes without a linear rise in overhead.
  • Expansion of therapy and rehabilitation pathways: Injury resolution increasingly relies on structured rehabilitation and follow-up protocols, supporting higher service intensity per case.
  • Fragmentation and provider consolidation: The industry often consolidates where standardized processes and contracting discipline drive better operational economics.

Over a 5–10 year horizon, the total addressable market is supported by the need for occupational healthcare delivery in a steady industrial base, combined with healthcare cost and productivity pressures that favor providers capable of managing care end-to-end rather than delivering isolated encounters.

⚠ Risk Factors to Monitor

  • Contract and payer reimbursement pressure: Changes in negotiated rates, payer mix, or utilization controls can compress margins.
  • Labor and staffing constraints: The ability to recruit and retain clinicians and therapists influences throughput, quality, and cost structure.
  • Regulatory and compliance risk: Occupational healthcare workflows intersect with documentation, coding, and claims processes; enforcement or contract compliance failures can be costly.
  • Capital intensity and real estate execution: Growth through new sites and upgrades requires disciplined capital allocation and site-level performance.
  • Operational quality variation across sites: Consistent protocol adherence is central to maintaining employer trust and referral patterns.

📊 Valuation & Market View

Equity valuation in clinic-based healthcare services commonly reflects cash-flow durability and operating leverage rather than long-duration growth narratives. Market participants often anchor on enterprise value to EBITDA or earnings-based multiples, while paying close attention to:

  • Organic clinic-level growth (site maturity, utilization, and patient mix).
  • Operating margin trajectory (labor productivity, reimbursement dynamics, and therapy intensity per case).
  • Contracting and employer retention as a proxy for switching cost strength.
  • Free cash flow conversion relative to capital spending.

Key valuation “needle movers” typically relate to evidence of sustained utilization, stable reimbursement economics, and disciplined cost management that translates into improving or resilient cash generation.

🔍 Investment Takeaway

CON’s investment case rests on an occupational healthcare delivery model that embeds into employer workflows, generating meaningful switching costs through administrative integration, continuity of care, and contracted network relationships. When operational execution supports clinic throughput, clinician productivity, and standardized care pathways, the model can produce durable cash flows despite cyclical healthcare utilization. The principal diligence focus centers on reimbursement resilience, staffing stability, and consistent site-level quality that sustains employer trust and contract longevity.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CON.

zacks.com2026-05-25

CON or ALHC: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Alignment Healthcare (ALHC). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-05-25

Wall Street Analysts Think Concentra (CON) Could Surge 25.24%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Concentra (CON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

seekingalpha.com2026-05-19

Concentra Group Holdings Parent, Inc. (CON) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Concentra Group Holdings Parent, Inc. (CON) Presents at Bank of America Global Healthcare Conference 2026 Transcript

marketbeat.com2026-05-09

Concentra Group Holdings Parent Q1 Earnings Call Highlights

Concentra Group Holdings Parent NYSE: CON reported double-digit revenue and adjusted EBITDA growth for the first quarter of 2026, citing stronger workers' compensation visit volumes, acquisitions and improved cost control as key drivers of the results.

seekingalpha.com2026-05-08

Concentra Group Holdings Parent, Inc. (CON) Q1 2026 Earnings Call Transcript

Concentra Group Holdings Parent, Inc. (CON) Q1 2026 Earnings Call Transcript

zacks.com2026-05-07

Concentra Group (CON) Q1 Earnings and Revenues Beat Estimates

Concentra Group (CON) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.32 per share a year ago.

prnewswire.com2026-05-07

CON EDISON REPORTS 2026 FIRST QUARTER EARNINGS

NEW YORK, May 7, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) today reported 2026 first quarter net income for common stock of $924 million or $2.55 a share compared with $791 million or $2.26 a share in the 2025 first quarter. Adjusted earnings (non-GAAP) were $790 million or $2.18 a share in the 2026 period compared with $792 million or $2.26 a share in the 2025 period.

businesswire.com2026-05-07

Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by number of locations, today announced results for its first quarter ended March 31, 2026, the declaration of a cash dividend, and raised guidance for full year 2026. “Our strong start to 2026 is a testament to the trust our clients place in us to care for their most valuable asset: their people,” sa.

zacks.com2026-05-04

CON vs. COR: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Cencora (COR). But which of these two stocks presents investors with the better value opportunity right now?

seekingalpha.com2026-04-30

Concentra Group Holdings Parent, Inc. (CON) Shareholder/Analyst Call Prepared Remarks Transcript

Concentra Group Holdings Parent, Inc. (CON) Shareholder/Analyst Call Prepared Remarks Transcript

prnewswire.com2026-04-16

CON EDISON DECLARES COMMON STOCK DIVIDEND

NEW YORK, April 16, 2026 /PRNewswire/ -- Consolidated Edison, Inc. (Con Edison) (NYSE: ED) declared a quarterly dividend of 88.75 cents a share on its common stock, payable June 15, 2026 to stockholders of record as of May 13, 2026. Consolidated Edison, Inc. is a holding company that provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc., a regulated utility providing electric service in New York City and New York's Westchester County, gas service in Manhattan, the Bronx, parts of Queens and parts of Westchester, and steam service in Manhattan; Orange and Rockland Utilities, Inc., a regulated utility serving customers in a 1,300-square mile area in southeastern New York State and northern New Jersey; and Con Edison Transmission, Inc., a regulated company primarily under the oversight of the Federal Energy Regulatory Commission, that develops and invests in electric transmission projects and owns, through joint ventures, both electric and gas assets.

businesswire.com2026-04-14

Concentra Chief Medical Officer Dr. Anderson to Retire After 33 Years

ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra,” the “Company,” “we,” “us,” or “our”) (NYSE: CON), the nation's largest provider of occupational health services by number of locations, today announced that Dr. John Anderson, executive vice president and Chief Medical Officer (CMO), will retire from Concentra at the end of the year. Dr. Anderson plans to advise the company as part of a consulting arrangement following his planned departure. The company has ini.

zacks.com2026-04-14

Will Concentra (CON) Beat Estimates Again in Its Next Earnings Report?

Concentra (CON) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

businesswire.com2026-04-09

Concentra to Announce First Quarter 2026 Results on Thursday, May 7, 2026

ADDISON, Texas--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, May 8, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com.

defenseworld.net2026-04-08

Concentra Group Holdings Parent, Inc. $CON Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC grew its holdings in shares of Concentra Group Holdings Parent, Inc. (NYSE: CON) by 168.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,711 shares of the company's stock after purchasing an additional 38,093 shares

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"CON delivered Q1’26 revenue of $569.6M, up 13.7% YoY (vs. $500.8M in Q1’25) and up 5.6% QoQ (vs. $539.1M in Q4’25). Net income was $50.5M, up 29.7% YoY (vs. $38.9M) and up 45.5% QoQ (vs. $34.7M). EPS was $0.39, rising from $0.31 YoY and from $0.28 QoQ. Profitability improved across the quarter: gross margin expanded to 29.9% from 28.7% YoY and 26.1% QoQ, while net margin rose to 8.9% from 7.8% YoY and 6.4% QoQ. However, operating income reported at $0.07M is distorted by unusually large “other” income/expense items, so operating profitability should be interpreted cautiously; the bottom-line still strengthened materially. Cash flow was mixed in quality. Operating cash flow was $21.0M in Q1’26 versus $11.7M in Q1’25 but down sharply from $118.7M in Q4’25. Free cash flow was $9.9M (positive) after capex of $11.1M. Shareholder support included $8.0M dividends paid and $15.0M buybacks. Balance sheet resilience looks stable (total assets $2.89B; equity $432M). Net debt remains high at ~$498M, but liquidity is adequate with $61.7M cash. Total shareholder returns were positive: the stock is up 11.2% over 1Y and 17.8% YTD, with no evidence of outsized momentum. Analyst consensus target is $31 versus the $22.86 price, implying upside."

Revenue Growth

Good

Revenue increased 13.7% YoY in Q1’26 ($569.6M vs. $500.8M) and 5.6% QoQ ($539.1M in Q4’25). Growth is positive and supported by improving margins.

Profitability

Positive

Net income rose 29.7% YoY and 45.5% QoQ. Net margin improved to 8.9% from 7.8% YoY and 6.4% QoQ; gross margin also expanded (29.9% vs. 28.7% YoY, 26.1% QoQ). Operating income is distorted by other items, but bottom-line profitability improved clearly.

Cash Flow Quality

Neutral

Operating cash flow was $21.0M in Q1’26—up YoY vs. $11.7M but down vs. $118.7M in Q4’25. Free cash flow was positive at $9.9M, with dividends ($8.0M) and buybacks ($15.0M) indicating continued capital return.

Leverage & Balance Sheet

Fair

Total assets rose to $2.89B from $3.04B QoQ, while equity increased to ~$432M (vs. ~$420M). Leverage remains elevated: total debt ~$560M and net debt ~$498M; liquidity is modest with $61.7M cash.

Shareholder Returns

Neutral

Price performance is positive but not momentum-driven (1Y +11.2%; no >20% 1Y change). Q1’26 included dividends ($8.0M) and buybacks ($15.0M), supporting shareholder returns.

Analyst Sentiment & Valuation

Positive

Consensus price target is $31 vs. $22.86, suggesting meaningful upside. However, operating metrics appear noisy due to large other-line items, which can temper confidence.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Concentra delivered a strong Q1 2026 characterized by outsized workers’ compensation momentum and continued operating leverage. Revenue rose to $569.6M (+13.7% YoY), and adjusted EBITDA increased to $120.7M, lifting margin by 69 bps to 21.2%. Growth was driven by higher-than-expected workers’ comp visits per day (+9.6%), revenue per visit up 3.1% (supported by +2% workers’ comp and +2.7% employer services), and improved cost of services as a share of revenue (70.1% vs 71.3%). Guidance was revised upward across revenue, EBITDA, and free cash flow, with free cash flow specifically strengthened at the low end ($215M-$235M). Capital returned via ~$15M buybacks plus $8M dividends, while leverage trended down to 3.4x and management reiterated an end-2026 target below 3.0x. Key near-term swing factors are workers’ comp fee schedule timing (Tennessee in Q2; Arizona in summer/early fall) and state-specific rate uncertainty, notably New York.

AI IconGrowth Catalysts

  • Workers' compensation visits per day up 9.6% and employer services visits per day up 4.8% (Q1 2026), supported by improved patient satisfaction and account management/retention technologies
  • Revenue per visit up 3.1% (from $147 to $151), driven by workers' comp revenue per visit +2% (from $209 to $213) and employer services +2.7% (from $94 to $97)
  • Service level metrics (avg patient time, Google ratings, patient NPS) at or close to historical bests
  • California workers' compensation rate increase effective March 1 expected to create upside for the remainder of 2026

Business Development

  • Completed integration of Nova (March 2025 acquisition) and captured all expected synergies; tracking toward transaction multiple below 7.5x adjusted EBITDA
  • Integration complete for Pivot On-site Innovations (June 2025 acquisition); ahead of original estimate transaction multiple below 9x adjusted EBITDA
  • Added three centers via acquisition in Q1 and one de novo center outside Atlanta
  • Planned 2026 de novo openings: 8 to 10 centers with planned locations in Arizona, Idaho, Missouri, Illinois, Virginia, South Carolina, and Florida

AI IconFinancial Highlights

  • Total revenue $569.6M (+13.7% YoY); excluding Nova revenue $520.3M (+6.3% YoY)
  • Adjusted EBITDA $120.7M (+17.6% YoY); adjusted EBITDA margin +69 bps to 21.2% (from 20.5%)
  • Adjusted EPS $0.40 vs $0.33 prior year; adjusted net income attributable $51.5M
  • Occupational health centers: Q1 revenue $487.8M (+5.7% YoY) and visits per day +2.9% excluding Nova
  • On-site health clinics: reported revenue $37.2M (+125% YoY), driven by Pivot; excluding Pivot revenue +20.9% YoY; nearing ~$150M run-rate
  • Cost of services improved to 70.1% of revenue (from 71.3%); G&A 9.7% of revenue (from 9.3%) with adjusted EBITDA margin benefit
  • Cash flow: operating cash flow $21.0M (vs $11.7M); free cash flow $9.9M (vs -$4.0M prior year)
  • Financing: repurchased ~661k shares totaling ~$15M and paid $8M dividends; repurchase authorization remaining ~$65M
  • 2026 guidance raised: revenue to $2.275B-$2.375B (increase $25M to both ends); adjusted EBITDA to $460M-$480M (increase $10M to both ends); free cash flow to $215M-$235M (low end +$15M, high end +$10M)

AI IconCapital Funding

  • Share repurchase: ~661k shares repurchased for ~$15M in Q1 2026
  • Remaining buyback capacity: ~$65M under board-authorized program at quarter end
  • Dividends: $8M paid in Q1; declared $0.0625/share payable ~06/09/2026 (record date close of business May 2026)
  • Balance sheet: total debt $1.58B; cash $61.7M
  • Net leverage: 3.4x at March (per credit agreement), slightly down vs year-end; expects decline to accelerate through remainder of year
  • Guidance: expects to end 2026 comfortably below 3.0x net leverage

AI IconStrategy & Ops

  • Separation from Select: hired >95% of expected new FTEs; expects functional separation by end of summer 2026, ahead of November 2026 deadline
  • Back-office technology separation milestones to complete over next month or so
  • Center-level margin improved via staffing efficiency gains
  • Weather management: aggressive center opening despite closure days; net impact viewed as positive vs Q1 2025 due to more slips/falls this year but fewer/limited shutdowns
  • On-site clinics growth: Epic deployed ~1.5 years ago; advanced primary care traction is now a key strategic white space

AI IconMarket Outlook

  • 2026 de novo cadence: total 8 to 10 openings expected in 2026 with specified states (AZ, ID, MO, IL, VA, SC, FL) and additional geographies via pipeline
  • Workers' comp pricing: California rate increase effective March 1; company expects 3% revenue-per-visit rate growth for the year 'potentially higher' (mix/timing driven)
  • Further workers' comp fee schedule step-ups: management indicated ~75%-80% of typical annual adjustments occur in Q1; next meaningful step-up in Q2 for Tennessee; additional annual updates in summer/early fall such as Arizona (magnitude uncertain but not expected 'too material')
  • New York rates: no update; management anticipates 'this year' with an assumed January 1 effective date; focused on E&M codes, PT not adjusted

AI IconRisks & Headwinds

  • Employer services remains below historical averages in a low-hire/low-fire environment, creating muted employer services trends even as workers' comp performs
  • Workers' comp fee schedule outcomes are subject to visit mix and timing; Q1 overall revenue per visit includes only one month of California upside (March 1 effective date)
  • Potential regulatory uncertainty on state rate updates (e.g., New York and other states such as Arizona) and variability in inflation-adjusted fee schedule changes
  • Q1 free cash flow is typically seasonally lowest; execution required to maintain leverage decline trajectory

Q&A: Analyst Interest

  • Q1 beat drivers vs consensus: Management said the upside came mainly from higher-than-expected workers' compensation visit volume plus cost of services and cost control via staffing execution across centers. They declined to comment on an internal budget number, emphasizing volume and cost as the two principal drivers.
  • Workers' comp rate trajectory and 3% target: Management confirmed revenue-per-visit was +3.1% overall, with workers' comp revenue per visit +2% and employer services +2.7%. California kicked in March 1, so Q1 lacked a full multi-month benefit; mix implies potential 2.3%-2.4% baseline without variability; still on track for 3%.
  • New York rate update timing and execution plan: Management reported no new update on New York rates, but expects resolution this year with a January 1 effective date. They expect to move 'pretty quickly' but remain selective, while continuing planned de novos and smaller organic M&A as Select decoupling and deleveraging progress.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the CON Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CON.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (CON)

© 2026 Stock Market Info — Concentra Group Holdings Parent, Inc. (CON) Financial Profile